Plasma IP-10 could identify early lung disease in severe COVID-19 patients

Autor:	Li Min Ling, Elampirai Elangovan, Mohammad Yazid Abdad, Kok Ooi Kong, Shawn Vasoo, Bernard Yu-Hor Thong, Bernard P. Leung, Hwee Siew Howe
Rok vydání:	2021
Předmět:	Lung Diseases medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry COVID-19 General Medicine Severity of Illness Index Gastroenterology Chemokine CXCL10 Lung disease Internal medicine medicine Humans business Biomarkers
Zdroj:	Annals of the Academy of Medicine, Singapore. 50:856-858
ISSN:	0304-4602
DOI:	10.47102/annals-acadmedsg.2021154
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf1c2f4d4200fb8aceb48ffd88029d9 https://doi.org/10.47102/annals-acadmedsg.2021154 Zobrazit plný text záznamu